PALLEIKO BENJAMIN L (CFO and Secretary) sold 0.8% of their position (3.35K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $52.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/13/2026ACC: 0001366244-26-000002
Officer· CFO and Secretary
Since Sep 2018
-3.35K
Net shares
Net seller
$52.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
7.12K acquired · 10.47K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.12K
Price / share
—
Trade value
—
% of position
1.7%
2/11/2026
424.52K→431.64K
Common Stock
Direct
Shares
−3.35K
Price / share
$15.70
Trade value
$52.66K
% of position
0.8%
2/12/2026
431.64K→428.29K
Total
Net shares
+3.77K
Net value
-$52.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/11/2026 | M · Option Exercise | +7.12K | — | — | 1.7% | 424.52K | 431.64K |
| Common Stock Direct | 2/12/2026 | S · Sale | −3.35K | $15.70 | $52.66K | 0.8% | 431.64K | 428.29K |
| Total | +3.77K | -$52.66K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
7.12K shares
Shares
−7.12K
Strike price
Held after
99.68K
Exercisable
—
2/11/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock7.12K shares | 2/11/2026 | M · Option Exercise | −7.12K | — | 99.68K |